Patent directory · USPTO A61K / A61P
Patents matching “antagonist”
678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11337971
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof
granted -
US 11337988
Use of ouabain antagonists to inhibit viral infection
granted -
US 11311549
Corticotropin releasing factor receptor antagonists
granted -
US 11306150
Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist
granted -
US 11299476
Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
granted -
US 11253572
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 11247969
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
AR 120033
ANTAGONISTA RADIOMARCADO DE GRPR PARA USO COMO AGENTE TERAGNÓSTICO
granted -
AR 119975
MÉTODOS PARA RADIOMARCAR ANTAGONISTAS DE GRPR Y SUS KITS
granted -
US 11229681
Dominant-negative FGF2 antagonists
granted -
US 11214621
Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
granted -
US 11208397
Small molecule antagonists of sumo related modification of CRMP2 and uses thereof
granted -
US 11202784
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted -
US 11186577
Vasopressin receptor antagonists and products and methods related thereto
granted -
US 11185554
Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease
granted -
US 11179370
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
granted -
US 11173118
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
granted -
US 11155523
Biphenyl compound as CCR2/CCR5 receptor antagonist
granted -
US 11154556
Methods of treating solid tumors with CCR2 antagonists
granted -
US 11141452
Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain
granted -
US 11136315
CXCR2 antagonist
granted -
US 11124489
EPAC antagonists
granted -
US 11124504
Kappa opioid receptor antagonists and products and methods related thereto
granted -
US 11111270
Inhibitor of apoptosis protein (IAP) antagonists
granted